Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

High-dose cyclophosphamide in the treatment of multiple sclerosis.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab.
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
Melatonin pathway genes are associated with progressive subtypes and disability status in multiple sclerosis among Finnish patients.
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.
B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
IgM antibody identifies good candidates for natalizumab
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
Dual role of Response gene to complement-32 in multiple sclerosis.

Pages